LC-MS/MS acquisitions For the discovery cohort, untargeted analysis samples were analyzed by nanoLC/MSMS using a Dionex UltiMate 3000 nanoRSLC liquid chromatography system (Thermo Fisher Scientific) interfaced to an Orbitrap Fusion Tribrid mass spectrometer (Thermo Fisher Scientific, San Jose, CA,USA) equipped with a nanoelectrospray ion source
After the isolation procedure, every time, the purity of the obtained RNA was checked by estimating the A260 nm/A280 nm ratio
Only use room temperature storage for transit periods of a few days at most
Abbreviations ACEI: Angiotensin-converting enzyme inhibitors aHR: Adjusted hazard ratio AMI: Acute myocardial infarction ARB: Angiotensin II receptor blockers BMI: Body mass index CVD: Cardiovascular diseases CVOT: Cardiovascular outcome trial CI: Confidence interval CKD: Chronic kidney disease DM: Diabetes mellitus DPP-4i: Dipeptidyl peptidase-4 inhibitor eGFR: Estimated glomerular filtration rate ESKD: End-stage kidney disease GLP-1 RA: Glucagon-like peptide-1 receptor agonist HbA1c: Glycated hemoglobin HCOs: Healthcare organizations IQR: Interquartile range KTR: Kidney transplant recipient MACE: Major adverse cardiovascular events MAKE: Major kidney event PSM: Propensity score matching PTDM: Post-transplant diabetes mellitus RCTs: Randomized clinical trials SBP: Systolic blood pressure SD: Standard deviation SGLT2i: Sodium-glucose cotransporter 2 inhibitor SU: Sulfonylureas T2DM: Type 2 diabetes mellitus TZD: Thiazolidinediones References Rangaswami J, Mathew RO, Parasuraman R, Tantisattamo E, Lubetzky M, Rao S, Yaqub MS, Birdwell KA, Bennett W, Dalal P, et al
Among these are the GLP-1 receptor agonists, which have demonstrated greater efficacy for glycemic control than other classic drugs such as sulfonylureas, thiazolidinediones and insulin, and even with other incretinomimetics such as dipeptidylpeptidase inhibitors 4
Protein disulfide isomerase PDI-6 regulates Wnt secretion to coordinate intertissue UPR(mt) activation and lifespan extension in C
